Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis

NCT00630279 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

56

Enrollment

INDUSTRY

Sponsor class

Stopped This trial discontinued March 7,2009 due to high screen failure rate.

Conditions

Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis

Interventions

DRUG: Placebo
DRUG: Recombinant Microbial Lipase SLV339
DRUG: Recombinant Microbial Lipase SLV339
DRUG: Recombinant Microbial Lipase SLV339

Sponsor

Solvay Pharmaceuticals